[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zeng et al., 2022 - Google Patents

Advances in phosphoproteomics and its application to COPD

Zeng et al., 2022

Document ID
14071428608427545804
Author
Zeng X
Lan Y
Xiao J
Hu L
Tan L
Liang M
Wang X
Lu S
Peng T
Long F
Publication year
Publication venue
Expert Review of Proteomics

External Links

Snippet

Introduction Chronic obstructive pulmonary disease (COPD) was the third leading cause of global death in 2019, causing a huge economic burden to society. Therefore, it is urgent to identify specific phenotypes of COPD patients through early detection, and to promptly treat …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N2030/0075—Separation due to differential desorption
    • G01N2030/008—Thermal desorption
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material

Similar Documents

Publication Publication Date Title
Crutchfield et al. Advances in mass spectrometry-based clinical biomarker discovery
Cifani et al. Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease
Liu et al. pGlyco 2.0 enables precision N-glycoproteomics with comprehensive quality control and one-step mass spectrometry for intact glycopeptide identification
Greco et al. Applications of MALDI-TOF mass spectrometry in clinical proteomics
Fang et al. Glyco-Decipher enables glycan database-independent peptide matching and in-depth characterization of site-specific N-glycosylation
Evans et al. An insight into iTRAQ: where do we stand now?
Hermann et al. Identification and characterization of post-translational modifications: Clinical implications
Stalmach et al. Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications
Paša-Tolić et al. Proteomic analyses using an accurate mass and time tag strategy
Cho et al. Oncoproteomics: current trends and future perspectives
Domon et al. Recent advances in targeted proteomics for clinical applications
Kolli et al. Engaging challenges in glycoproteomics: recent advances in MS-based glycopeptide analysis
Mazur et al. Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry
Pham et al. Label-free mass spectrometry-based proteomics for biomarker discovery and validation
Hsu et al. Stable isotope dimethyl labelling for quantitative proteomics and beyond
Bakry et al. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review
Brzhozovskiy et al. The parallel reaction monitoring-parallel accumulation–serial fragmentation (prm-PASEF) approach for multiplexed absolute quantitation of proteins in human plasma
Issaq et al. Global proteomics and metabolomics in cancer biomarker discovery
Lin et al. Mass spectrometry‐based targeted proteomics for analysis of protein mutations
Domon et al. Implications of new proteomics strategies for biology and medicine
Tucholski et al. Fourier‐transform ion cyclotron resonance mass spectrometry for characterizing proteoforms
Thomas et al. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics
Ding et al. Quantitative proteomic approaches for studying phosphotyrosine signaling
Albalat et al. Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications
Liang et al. Progress of proteomics‐driven precision medicine: From a glycosylation view